The University of Chicago Header Logo

Connection

Jason X. Cheng to Aged

This is a "connection" page, showing publications Jason X. Cheng has written about Aged.
Connection Strength

0.390
  1. Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment. Eur J Surg Oncol. 2019 Aug; 45(8):1498-1504.
    View in: PubMed
    Score: 0.049
  2. Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy. Oncotarget. 2016 Jul 12; 7(28):44224-44235.
    View in: PubMed
    Score: 0.041
  3. Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma. Chronobiol Int. 2016; 33(2):210-9.
    View in: PubMed
    Score: 0.039
  4. Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity. World J Surg Oncol. 2014 Nov 06; 12:329.
    View in: PubMed
    Score: 0.036
  5. Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome. Leukemia. 2013 Jun; 27(6):1291-300.
    View in: PubMed
    Score: 0.032
  6. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study. J Surg Oncol. 2008 Jul 01; 98(1):34-41.
    View in: PubMed
    Score: 0.023
  7. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008 Jun; 21(6):647-52.
    View in: PubMed
    Score: 0.023
  8. Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment? J Surg Oncol. 2007 Aug 01; 96(2):144-50.
    View in: PubMed
    Score: 0.022
  9. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.018
  10. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood Cancer Discov. 2024 May 01; 5(3):164-179.
    View in: PubMed
    Score: 0.017
  11. Ozanimod-exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histological Changes. J Crohns Colitis. 2024 Apr 23; 18(4):638-641.
    View in: PubMed
    Score: 0.017
  12. Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience. Oncology. 2024; 102(11):913-923.
    View in: PubMed
    Score: 0.017
  13. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 15; 57(4):1010-8.
    View in: PubMed
    Score: 0.017
  14. A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands. Head Neck Pathol. 2018 Jun; 12(2):286-290.
    View in: PubMed
    Score: 0.011
  15. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease? Dig Surg. 2018; 35(2):104-110.
    View in: PubMed
    Score: 0.011
  16. Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resection. Ann Surg Oncol. 2014 Nov; 21(12):3992-8.
    View in: PubMed
    Score: 0.009
  17. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013 Nov 21; 122(22):3599-606.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.